Shockwave Medical, Inc.

NasdaqGS:SWAV 株式レポート

時価総額：US$12.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Shockwave Medical マネジメント

マネジメント 基準チェック /44

現在、CEO に関する十分な情報がありません。

主要情報

Doug Godshall

最高経営責任者

US$9.5m

報酬総額

CEO給与比率7.6%
CEO在任期間7yrs
CEOの所有権0.3%
経営陣の平均在職期間2.3yrs
取締役会の平均在任期間5.3yrs

経営陣の近況

Recent updates

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Apr 06
Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Mar 24
Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18
Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06
There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24
Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09
Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Dec 27
Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Dec 13
Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Nov 17
What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

Oct 19
Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Oct 06
Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

Sep 20
Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Sep 07
Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?

Jul 10
When Should You Buy Shockwave Medical, Inc. (NASDAQ:SWAV)?

We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

Jun 26
We Think Shockwave Medical (NASDAQ:SWAV) Might Have The DNA Of A Multi-Bagger

We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease

Jun 13
We Think Shockwave Medical (NASDAQ:SWAV) Can Manage Its Debt With Ease

Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?

May 29
Is Now The Time To Put Shockwave Medical (NASDAQ:SWAV) On Your Watchlist?

CEO報酬分析

Shockwave Medical の収益と比較して、Doug Godshall の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

US$163m

Dec 31 2023US$9mUS$716k

US$147m

Sep 30 2023n/an/a

US$244m

Jun 30 2023n/an/a

US$244m

Mar 31 2023n/an/a

US$241m

Dec 31 2022US$8mUS$644k

US$216m

Sep 30 2022n/an/a

US$88m

Jun 30 2022n/an/a

US$55m

Mar 31 2022n/an/a

US$29m

Dec 31 2021US$7mUS$575k

-US$9m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$53m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$5mUS$546k

-US$66m

Sep 30 2020n/an/a

-US$65m

Jun 30 2020n/an/a

-US$65m

Mar 31 2020n/an/a

-US$57m

Dec 31 2019US$2mUS$477k

-US$51m

Sep 30 2019n/an/a

-US$48m

Jun 30 2019n/an/a

-US$45m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$511kUS$376k

-US$41m

報酬と市場: Dougの 総報酬 ($USD 9.48M ) は、 US市場 ($USD 13.55M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Dougの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Doug Godshall (58 yo)

7yrs

在職期間

US$9,478,729

報酬

Mr. Douglas E. Godshall, also known as Doug, M.B.A., is Director of Saluda Medical, Inc. He serves as Chair of the Board of Galvanize Therapeutics, Inc. since September 2022. He has been the Chief Executiv...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Douglas Godshall
President7yrsUS$9.48m0.29%
$ 36.5m
Isaac Zacharias
President & Chief Commercial Officer1.9yrsUS$3.23m0.15%
$ 18.8m
Daniel Hawkins
Founder and Senior Advisor15.3yrsデータなしデータなし
John Adams
Co-Founder and Technical Advisor15.3yrsデータなしデータなし
Renee Gaeta
Chief Financial Officerless than a yearデータなし0.053%
$ 6.7m
Luis Morales
Senior Vice President of Global Operationsless than a yearデータなしデータなし
Trinh Phung
Chief Accounting Officer2.3yrsデータなし0.13%
$ 16.9m
Debbie Kaster
Vice President of Investor Relationsless than a yearデータなしデータなし
Hajime Tada
General Counsel & Secretary4.9yrsデータなしデータなし
Robert Fletcher
Senior Vice President of Marketing & Market Access7.8yrsデータなしデータなし
Dave Cox
Vice President of Salesless than a yearデータなしデータなし
Cathy Harnett
Senior Director of Human Resources2.3yrsデータなしデータなし

2.3yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: SWAVの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Douglas Godshall
President7yrsUS$9.48m0.29%
$ 36.5m
Antoine Papiernik
Independent Director10.8yrsUS$277.06kデータなし
Frederic Moll
Independent Director13yrsUS$273.62k0.76%
$ 95.7m
Charles Larkin
Independent Chairman of the Board5.3yrsUS$333.62k0.012%
$ 1.5m
Laura Francis
Independent Director5.3yrsUS$297.37k0.011%
$ 1.4m
Sara Toyloy
Independent Director3.2yrsUS$278.62k0.0052%
$ 651.0k
Maria Sainz
Independent Director3.8yrsUS$289.87k0.0096%
$ 1.2m
Kevin Ballinger
Independent Directorless than a yearUS$508.05kデータなし
F. Watkins
Independent Director10.9yrsUS$278.62k0.010%
$ 1.3m

5.3yrs

平均在職期間

57yo

平均年齢

経験豊富なボード: SWAVの 取締役会 は 経験豊富 であると考えられます ( 5.3年の平均在任期間)。